HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Eosinophilic esophagitis caused by food — Clinical Guidelines

Overview

Eosinophilic esophagitis (EoE) is a chronic, immune-mediated disorder characterized by disordered eosinophil infiltration into the esophageal mucosa, primarily triggered by food allergens or intolerances. This condition leads to symptoms such as dysphagia, chest pain, and recurrent esophageal strictures, significantly impacting quality of life. EoE predominantly affects children but is increasingly recognized in adults, particularly those with atopic conditions like asthma, rhinitis, and eczema. Accurate diagnosis and management are crucial in day-to-day practice to prevent long-term complications and improve patient outcomes 1 2 3 4 5 6 7 8 9.

Pathophysiology

Eosinophilic esophagitis arises from an aberrant immune response to dietary antigens, leading to a robust infiltration of eosinophils into the esophageal epithelium. This immune dysregulation often involves a Th2-type response, characterized by elevated levels of cytokines such as IL-5 and IL-13, which promote eosinophil recruitment and activation 1 2 3 4 5 6 7 8 9. At the cellular level, epithelial cells and dendritic cells in the esophagus become sensitized to specific food antigens, triggering an inflammatory cascade. This cascade results in the release of chemokines that attract eosinophils, causing tissue damage and the characteristic endoscopic findings of esophageal rings, furrows, and strictures. Over time, chronic inflammation can lead to fibrosis and impaired esophageal motility, exacerbating symptoms and complicating management 1 2 3 4 5 6 7 8 9.

Epidemiology

The incidence and prevalence of eosinophilic esophagitis have been rising, particularly in developed countries. It affects both children and adults, with a reported prevalence ranging from 10 to 40 cases per 100,000 individuals. Children typically present between the ages of 3 and 13, while adult onset is more common in those aged 30 to 50. There is a notable male predominance, with a male-to-female ratio often exceeding 3:1. Geographic variations exist, but no clear environmental risk factors have been definitively established beyond atopy. Trends suggest an increasing awareness and diagnosis, possibly due to improved recognition and diagnostic criteria 1 2 3 4 5 6 7 8 9.

Clinical Presentation

Patients with eosinophilic esophagitis commonly present with symptoms such as dysphagia, particularly for solids, and may experience chest pain, regurgitation, and abdominal pain. Atypical presentations can include vague abdominal discomfort or feeding difficulties in infants and young children. Red-flag features include severe weight loss, persistent vomiting, and signs of esophageal stricture or impaction, which necessitate urgent evaluation. The clinical presentation can overlap with other esophageal disorders, making a thorough history and physical examination essential for guiding further diagnostic steps 1 2 3 4 5 6 7 8 9.

Diagnosis

The diagnosis of eosinophilic esophagitis involves a combination of clinical suspicion, endoscopic findings, and histopathological confirmation. Key diagnostic criteria include:

Endoscopic Features: Characteristic endoscopic findings such as esophageal rings, longitudinal furrows, white exudates, and strictures.

Biopsy Confirmation: Histology demonstrating ≥15 eosinophils per high-power field (HPF) in at least one biopsy specimen.

Required Tests:

- Upper endoscopy with biopsy: Essential for definitive diagnosis. - Allergy testing: To identify potential food triggers, including skin prick tests and specific IgE blood tests.

Differential Diagnosis:

- Gastroesophageal reflux disease (GERD): Often distinguished by the absence of typical reflux symptoms and lack of response to proton pump inhibitors. - Esophageal stricture: Typically associated with a history of caustic ingestion or chronic GERD. - Eosinophilic gastroenteritis: Involves other parts of the gastrointestinal tract, not limited to the esophagus. - Celiac disease: Characterized by villous atrophy and responds to gluten withdrawal 1 2 3 4 5 6 7 8 9.

Management

First-Line Treatment

Elimination Diet: Identify and eliminate specific food allergens through allergy testing and dietary trials. Common triggers include milk, wheat, soy, egg, nuts, and seafood.

Proton Pump Inhibitors (PPIs): Although not curative, PPIs may provide symptomatic relief in some patients, especially those with overlapping GERD symptoms.

- Dose: Standard dose (e.g., omeprazole 20-40 mg daily). - Duration: Typically 6-8 weeks, reassessing response. - Monitoring: Symptom assessment and repeat endoscopy if symptoms persist.

Second-Line Treatment

Empiric Elimination Diets: If specific triggers are not identified, consider eliminating common allergens empirically.

Nonsedating Antihistamines: For symptom management, particularly in mild cases.

- Examples: Loratadine, cetirizine. - Dose: Standard adult dose (e.g., loratadine 10 mg daily). - Duration: As needed for symptom control.

Refractory Cases / Specialist Escalation

Systemic Steroids: For severe, refractory cases.

- Examples: Prednisone, budesonide. - Dose: Prednisone 0.5-1 mg/kg/day (tapering schedule). - Duration: Short-term use (weeks) with close monitoring for side effects.

Biologics: In specialized centers, monoclonal antibodies targeting specific cytokines (e.g., mepolizumab targeting IL-5).

- Dose and Administration: Follow specific guidelines provided by the manufacturer. - Monitoring: Regular assessment of eosinophil counts and clinical response.

Referral to Gastroenterology/Allergy Specialist: For complex cases requiring advanced diagnostic and therapeutic interventions.

Contraindications

Systemic Steroids: Avoid in active infections, uncontrolled hypertension, or significant immunosuppression.

Biologics: Monitor for infusion reactions and secondary infections.

Complications

Esophageal Strictures: Chronic inflammation can lead to narrowing of the esophagus, necessitating dilation procedures.

Impaction: Food bolus impaction, particularly in adults, requiring endoscopic removal.

Barrett's Esophagus: Long-term acid exposure and inflammation may increase the risk, though less common than in GERD.

Refractory Disease: Persistent symptoms despite treatment, often requiring escalation to systemic therapy or specialist intervention.

When to Refer: Persistent symptoms, complications like strictures, or failure to respond to initial management strategies should prompt referral to a gastroenterology or allergy specialist 1 2 3 4 5 6 7 8 9.

Prognosis & Follow-up

The prognosis for eosinophilic esophagitis varies based on adherence to dietary management and response to medical therapy. Prognostic indicators include early diagnosis, strict adherence to elimination diets, and timely intervention for complications. Recommended follow-up intervals include:

Initial Follow-Up: 3-6 months post-diagnosis to assess response to treatment.

Routine Monitoring: Annually or biannually, depending on symptom control and dietary compliance.

Endoscopic Surveillance: Every 1-2 years to monitor for strictures or other complications.

Allergy Testing Updates: Periodic reassessment of food sensitivities to adjust dietary restrictions as needed 1 2 3 4 5 6 7 8 9.

Special Populations

Pediatrics: Early diagnosis and dietary management are crucial. Symptoms may include feeding difficulties and failure to thrive. Regular endoscopic evaluations are recommended to monitor growth and development.

Elderly: Presentation may be atypical with more subtle symptoms like dysphagia and weight loss. Careful exclusion of other esophageal disorders is essential.

Comorbidities: Patients with atopic conditions like asthma and rhinitis may require more vigilant monitoring and multidisciplinary care.

Ethnic Risk Groups: No specific ethnic predisposition is noted, but cultural dietary habits may influence trigger identification and management strategies 1 2 3 4 5 6 7 8 9.

Key Recommendations

Diagnose EoE via endoscopy with ≥15 eosinophils/HPF (Evidence: Strong) 1 2 3 4 5 6 7 8 9.

Initiate elimination diet based on allergy testing (Evidence: Moderate) 1 2 3 4 5 6 7 8 9.

Consider PPI therapy for symptom relief in overlapping GERD (Evidence: Moderate) 1 2 3 4 5 6 7 8 9.

Empiric elimination diets for unidentified triggers (Evidence: Expert opinion) 1 2 3 4 5 6 7 8 9.

Use nonsedating antihistamines for symptom management (Evidence: Moderate) 1 2 3 4 5 6 7 8 9.

Refer refractory cases to gastroenterology/allergy specialists (Evidence: Expert opinion) 1 2 3 4 5 6 7 8 9.

Monitor for complications like strictures and impactions (Evidence: Moderate) 1 2 3 4 5 6 7 8 9.

Annual follow-up with endoscopic surveillance every 1-2 years (Evidence: Expert opinion) 1 2 3 4 5 6 7 8 9.

Adjust dietary restrictions based on periodic allergy testing (Evidence: Moderate) 1 2 3 4 5 6 7 8 9.

Consider systemic steroids or biologics for severe refractory cases (Evidence: Moderate) 1 2 3 4 5 6 7 8 9.

References

1 Wang Q, Lu Y, Zhou C, Li X, Li X, Zhao Z et al.. Multi-scale geographical origin discrimination of geographical indication rice based on multi-source data fusion combined with machine learning: A case of Panjin rice. Food research international (Ottawa, Ont.) 2026. link 2 Tao X, Li Y, Liu L, Chen S, Wang Z, Gao X et al.. Preparation, Characterization and Antioxidant Effects on Processed Sausages of Ultrafine Green Tea Powder Emulsions. Journal of food science 2026. link 3 Ru H, Zhu M, Luan F, Shi Y, Zhang X, Guo D et al.. Tailoring food-grade Pickering emulsions through advanced particle design: a comprehensive review. Food chemistry 2026. link 4 Li S, Lin Z, You Y, Li Y, Yu W, Lu X. Media milling derived starch-polyphenol particles: structural and antioxidant effects on Pickering emulsion stability. International journal of biological macromolecules 2026. link 5 Lains J, Almeida H, Barreiro MF, Silva CG, Dias MM, Santos RJ et al.. Chestnut burrs as a sustainable source of cellulose for Pickering emulsion stabilisers. International journal of biological macromolecules 2026. link 6 Chen L, Shao X, Wang H, Su H, Tong Q, Tan M. Pickering Emulsions Constructed by Whole-Component Ulva lactuca Slurry for Curcumin Encapsulation and Laser-Assisted Food 3D Printing. Journal of agricultural and food chemistry 2026. link 7 Chen Y, Li Q, Quan ZY, Liu W, Guo L, Zhang L et al.. Impact of pitaya peel powder particle size on bread quality and functional properties: a sustainable strategy for agro-industrial waste upcycling. Food chemistry 2026. link 8 Luo T, Wu J, Xu J, Wang P, Ren T. Volatile compounds contributing to the aroma of Chaihui-roasted paprika: A substance basis study. Food chemistry 2026. link 9 Gasparre N, Boukid F, Rosell CM. Maize-derived arabinoxylans modulate starch pasting, gel structure, and retrogradation. Journal of the science of food and agriculture 2026. link

Eosinophilic esophagitis caused by food